Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model. Issue 8 (August 2016)
- Record Type:
- Journal Article
- Title:
- Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model. Issue 8 (August 2016)
- Main Title:
- Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model
- Authors:
- Hibender, Stijntje
Franken, Romy
van Roomen, Cindy
ter Braake, Anique
van der Made, Ingeborg
Schermer, Edith E.
Gunst, Quinn
van den Hoff, Maurice J.
Lutgens, Esther
Pinto, Yigal M.
Groenink, Maarten
Zwinderman, Aeilko H.
Mulder, Barbara J.M.
de Vries, Carlie J.M.
de Waard, Vivian - Abstract:
- Abstract : Objective—: Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the fibrillin-1 gene. Patients with MFS are at risk of aortic aneurysm formation and dissection. Usually, blood pressure–lowering drugs are used to reduce aortic events; however, this is not sufficient for most patients. In the aorta of smooth muscle cell–specific sirtuin-1–deficient mice, spontaneous aneurysm formation and senescence are observed. Resveratrol is known to enhance sirtuin-1 activity and to reduce senescence, which prompted us to investigate the effectiveness of resveratrol in inhibition of aortic dilatation in the Fbn1 C1039G/+ MFS mouse model. Approach and Results—: Aortic senescence strongly correlates with aortic root dilatation rate in MFS mice. However, although resveratrol inhibits aortic dilatation, it only shows a trend toward reduced aortic senescence. Resveratrol enhances nuclear localization of sirtuin-1 in the vessel wall and, in contrast to losartan, does not affect leukocyte infiltration nor activation of SMAD2 and extracellular signal–regulated kinases 1/2 (ERK1/2). Interestingly, specific sirtuin-1 activation (SRT1720) or inhibition (sirtinol) in MFS mice does not affect aortic root dilatation rate, although senescence is changed. Resveratrol reduces aortic elastin breaks and decreases micro-RNA-29b expression coinciding with enhanced antiapoptotic Bcl-2 expression and decreased number of terminal apoptotic cells. In cultured smooth muscleAbstract : Objective—: Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the fibrillin-1 gene. Patients with MFS are at risk of aortic aneurysm formation and dissection. Usually, blood pressure–lowering drugs are used to reduce aortic events; however, this is not sufficient for most patients. In the aorta of smooth muscle cell–specific sirtuin-1–deficient mice, spontaneous aneurysm formation and senescence are observed. Resveratrol is known to enhance sirtuin-1 activity and to reduce senescence, which prompted us to investigate the effectiveness of resveratrol in inhibition of aortic dilatation in the Fbn1 C1039G/+ MFS mouse model. Approach and Results—: Aortic senescence strongly correlates with aortic root dilatation rate in MFS mice. However, although resveratrol inhibits aortic dilatation, it only shows a trend toward reduced aortic senescence. Resveratrol enhances nuclear localization of sirtuin-1 in the vessel wall and, in contrast to losartan, does not affect leukocyte infiltration nor activation of SMAD2 and extracellular signal–regulated kinases 1/2 (ERK1/2). Interestingly, specific sirtuin-1 activation (SRT1720) or inhibition (sirtinol) in MFS mice does not affect aortic root dilatation rate, although senescence is changed. Resveratrol reduces aortic elastin breaks and decreases micro-RNA-29b expression coinciding with enhanced antiapoptotic Bcl-2 expression and decreased number of terminal apoptotic cells. In cultured smooth muscle cells, the resveratrol effect on micro-RNA-29b downregulation is endothelial cell and nuclear factor κB-dependent. Conclusions—: Resveratrol inhibits aortic root dilatation in MFS mice by promoting elastin integrity and smooth muscle cell survival, involving downregulation of the aneurysm-related micro-RNA-29b in the aorta. On the basis of these data, resveratrol holds promise as a novel intervention strategy for patients with MFS. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Arteriosclerosis, thrombosis, and vascular biology. Volume 36:Issue 8(2016)
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Issue:
- Volume 36:Issue 8(2016)
- Issue Display:
- Volume 36, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 36
- Issue:
- 8
- Issue Sort Value:
- 2016-0036-0008-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-08
- Subjects:
- aortic aneurysm -- extracellular matrix -- Marfan syndrome -- micro-RNAs -- resveratrol -- sirtuin-1
Arteriosclerosis -- Periodicals
Thrombosis -- Periodicals
Blood-vessels -- Pathophysiology -- Periodicals
Electronic journals
616.13 - Journal URLs:
- http://atvb.ahajournals.org/contents-by-date.0.shtml ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/ATVBAHA.116.307841 ↗
- Languages:
- English
- ISSNs:
- 1079-5642
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1733.670000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5016.xml